RecallRadar

FDA Drug recall D-0335-2022

CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 60 mg Antihistamine, 12HR, packaged as a) 12 count bottle, NDC 59779-425-53, UPC 0…

On 2022-01-12 the FDA classified a Class II recall of CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 60 mg Antihistamine, 12HR, packaged as a) 12 count bottle, NDC 59779-425-53, UPC 0… by Perrigo, citing failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0335-2022
ClassificationClass II
Statusterminated
Initiated2021-07-27
Published2022-01-12
Last updated2026-09-13 11:52 UTC
CompanyPerrigo
DistributionUS

Product

CVS Allergy Relief, Fexofenadine Hydrochloride Tablets, 60 mg Antihistamine, 12HR, packaged as a) 12 count bottle, NDC 59779-425-53, UPC 0 50428 25414 1; b)24 count bottle, NDC 59779-425-62, UPC 0 50428 53435 9; Distributed by: CVS Pharmacy, Inc. One CVS Drive, Woonsocket, RI 02895, Made in Czech Republic

Reason

Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.

Identifiers

upc050428254141
upc050428534359
code_infoLot # a) 0ME2516, Exp 4/30/2022 b)0ME2515, Exp 4/30/2022; 0KE2982, Exp 1/31/2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0335-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.